|
RPS6KC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.248200E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.81309999997193E-06 |
| Normal-vs-Stage2 |
3.381100E-03 |
| Normal-vs-Stage3 |
9.315600E-01 |
| Normal-vs-Stage4 |
3.741000E-01 |
| Stage1-vs-Stage2 |
7.318400E-01 |
| Stage1-vs-Stage3 |
2.659900E-02 |
| Stage1-vs-Stage4 |
3.739600E-01 |
| Stage2-vs-Stage3 |
7.135600E-02 |
| Stage2-vs-Stage4 |
6.265800E-01 |
| Stage3-vs-Stage4 |
4.479400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.590100E-04 |
| Normal-vs-AfricanAmerican |
2.278600E-03 |
| Normal-vs-Asian |
5.488400E-01 |
| Caucasian-vs-AfricanAmerican |
8.877200E-01 |
| Caucasian-vs-Asian |
6.582600E-01 |
| AfricanAmerican-vs-Asian |
5.794000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.57099999997801E-06 |
| Normal-vs-Female |
8.675200E-01 |
| Male-vs-Female |
3.71450000000717E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.705500E-02 |
| Normal-vs-Extreme_Weight |
3.31430000000132E-07 |
| Normal-vs-Obese |
4.138400E-02 |
| Normal-vs-Extreme_Obese |
1.001850E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.406960E-01 |
| Normal_Weight-vs-Obese |
7.139200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.096200E-01 |
| Extreme_Weight-vs-Obese |
3.266200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.539600E-01 |
| Obese-vs-Extreme_Obese |
2.926000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.232200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.394150E-02 |
| Normal-vs-Age(61-80Yrs) |
1.54528999999348E-05 |
| Normal-vs-Age(81-100Yrs) |
8.97309999969842E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.227600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.988200E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.037000E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.853700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.562000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.231900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.2183000000231E-06 |
| Normal-VS-Type2 PRCC |
7.015200E-03 |
| Normal-VS-KIRP CIMP |
1.456390E-01 |
| Normal-VS-Unclassified PRCC |
4.629000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.794400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.107900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.119540E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.897820E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.794570E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.617500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.63570000000824E-05 |
| Normal-vs-N1 |
2.023200E-01 |
| Normal-vs-N2 |
7.467000E-01 |
| N0-vs-N1 |
6.163800E-03 |
| N0-vs-N2 |
3.071000E-01 |
| N1-vs-N2 |
4.649000E-01 |
|
|
